Fuel availability and fate in cardiac metabolism: A tale of two substrates

F Pascual, RA Coleman - Biochimica et Biophysica Acta (BBA)-Molecular …, 2016 - Elsevier
The heart's extraordinary metabolic flexibility allows it to adapt to normal changes in
physiology in order to preserve its function. Alterations in the metabolic profile of the heart …

Good and bad consequences of altered fatty acid metabolism in heart failure: evidence from mouse models

D Abdurrachim, JJFP Luiken, K Nicolay… - Cardiovascular …, 2015 - academic.oup.com
The shift in substrate preference away from fatty acid oxidation (FAO) towards increased
glucose utilization in heart failure has long been interpreted as an oxygen-sparing …

Rapamycin persistently improves cardiac function in aged, male and female mice, even following cessation of treatment

E Quarles, N Basisty, YA Chiao, G Merrihew, H Gu… - Aging …, 2020 - Wiley Online Library
Even in healthy aging, cardiac morbidity and mortality increase with age in both mice and
humans. These effects include a decline in diastolic function, left ventricular hypertrophy …

Prdm16 deficiency leads to age-dependent cardiac hypertrophy, adverse remodeling, mitochondrial dysfunction, and heart failure

DM Cibi, KW Bi-Lin, SG Shekeran, R Sandireddy… - Cell reports, 2020 - cell.com
Hypertrophic cardiomyopathy (HCM) is a well-established risk factor for cardiovascular
mortality worldwide. Although hypertrophy is traditionally regarded as an adaptive response …

Loss of long-chain acyl-CoA synthetase 1 promotes hepatocyte death in alcohol-induced steatohepatitis

H Dong, W Zhong, W Zhang, L Hao, W Guo, R Yue… - Metabolism, 2023 - Elsevier
Background Alcohol consumption has been shown to disrupt hepatic lipid homeostasis.
Long-chain acyl-CoA synthetase 1 (ACSL1) critically regulates hepatic fatty acid metabolism …

Loss of cardiac carnitine palmitoyltransferase 2 results in rapamycin-resistant, acetylation-independent hypertrophy

AS Pereyra, LY Hasek, KL Harris, AG Berman… - Journal of Biological …, 2017 - ASBMB
Cardiac hypertrophy is closely linked to impaired fatty acid oxidation, but the molecular basis
of this link is unclear. Here, we investigated the loss of an obligate enzyme in mitochondrial …

Lipids and diastolic dysfunction: Recent evidence and findings

P Daneii, S Neshat, MS Mirnasiry, Z Moghimi… - Nutrition, Metabolism …, 2022 - Elsevier
Aim Diastolic dysfunction is the decreased flexibility of the left ventricle due to the impaired
ability of the myocardium to relax and plays an important role in the pathogenesis of heart …

[HTML][HTML] Acyl-CoA synthetases as regulators of brain phospholipid acyl-chain diversity

RF Fernandez, JM Ellis - Prostaglandins, Leukotrienes and Essential Fatty …, 2020 - Elsevier
Each individual cell-type is defined by its distinct morphology, phenotype, molecular and
lipidomic profile. The importance of maintaining cell-specific lipidomic profiles is exemplified …

Effects of natural and synthetic astaxanthin on growth, body color, and transcriptome and metabolome profiles in the leopard coralgrouper (Plectropomus leopardus)

J Zhang, C Tian, K Zhu, Y Liu, C Zhao, M Jiang, C Zhu… - Animals, 2023 - mdpi.com
Simple Summary The leopard coralgrouper (Plectropomus leopardus) is highly valuable in
the ornamental fish market owing to its bright red color. Astaxanthin is commonly used as a …

Octanoate is differentially metabolized in liver and muscle and fails to rescue cardiomyopathy in CPT2 deficiency

AS Pereyra, KL Harris, AH Soepriatna… - Journal of Lipid …, 2021 - ASBMB
Long-chain fatty acid oxidation is frequently impaired in primary and systemic metabolic
diseases affecting the heart; thus, therapeutically increasing reliance on normally minor …